Resistance of Candida albicans biofilms to antifungal agents in vitro
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Biofilms formed by Candida albicans on small discs of catheter material were resistant to the action of five clinically important antifungal agents as determined by [3H]leucine incorporation and tetrazolium reduction assays. Fluconazole showed the greatest activity, and amphotericin B showed the least activity against biofilm cells. These findings were confirmed by scanning electron microscopy of the biofilms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Bacterial Biofilms in Nature and Disease
Costerton, J. W., Cheng, K. J., Geesey, G. G., Ladd, T. I., Nickel, J. C., Dasgupta, M., & Marrie, T. J. (1987) · Annual Review of Microbiology · doi:10.1146/annurev.mi.41.100187.002251 · Cited by 3,145
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
Gristina, A. G. (1987) · Science · doi:10.1126/science.3629258 · Cited by 2,156
Biofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599 · cited 8×
“The cells were harvested, washed twice in PBS, and resuspended in PBS (1 ml) containing [(3)H]leucine or MTT, and [(3)H]leucine incorporation or MTT-formazan formation was assayed as before (11).”
BackgroundMethodInfluentialSelf-citationSensitivity of biofilms to antimicrobial agents
Brown, M. R. W., & Gilbert, P. (1993) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1993.tb04345.x · Cited by 325
McCourtie, J., & Douglas, L. J. (1981) · Infection and Immunity · doi:10.1128/iai.32.3.1234-1241.1981 · Cited by 240
Self-citationPathogenesis of infections related to intravascular catheterization
Goldmann, D. A., & Pier, G. B. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.2.176 · Cited by 218
Pathobiology of Infection in Prosthetic Devices
Dougherty, S. H. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.6.1102 · Cited by 193
Intravascular-device infections
Elliott, T. (1988) · Journal of Medical Microbiology · doi:10.1099/00222615-27-3-161 · Cited by 89
Domingue, G. J., ELLIS, B., Dasgupta, M., & Costerton, J. W. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.10.2564-2568.1994 · Cited by 46
Cited by
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
“albicans (11, 21) and bacterial biofilms (7, 15), this is the first report correlating the emergence of antifungal resistance with the development of biofilms.”
BackgroundClinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Self-citationCandida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
“albicans in biofilms on polyvinyl chloride disks has been reported to be 30 to 2,000 times more resistant to fluconazole, amphotericin B, flucytosine, itraconazole, and ketoconazole than planktonic cells (44), and the biofilm structure remained intact at an amphotericin B concentration of 11 times the MIC.”
BackgroundSilva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
“Microbes adhere to the surface of foreign bodies, and this site appears to afford them a relative degree of protection from the action of antimicrobial agents [57, 58].”
BackgroundKuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 764
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Candida Biofilms: Threats, Challenges, and Promising Strategies
Cavalheiro, M., & Teixeira, M. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00028 · Cited by 690
“albicans were found to exhibit five- to eightfold higher resistance to all antifungals when compared to planktonic cells (97).”
BackgroundRamage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
Antifungal Resistance of Candidal Biofilms Formed on Denture Acrylic in vitro
Chandra, J., Mukherjee, P. K., Leidich, S. D., Faddoul, F. F., Hoyer, L. L., Douglas, L. J., & Ghannoum, M. A. (2001) · Journal of Dental Research · doi:10.1177/00220345010800031101 · Cited by 597
Self-citationRamage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
“albicans biofilms utilised some of the earliest models, from which quantitative assessment using dry weight measurements, tetrazolium salt (MTT) reduction assays, and incorporation of [3H] leucine were described [60, 61].”
MethodCandida biofilms on implanted biomaterials: a clinically significant problem
Ramage, G., MartÃnez, J. P., & López-Ribot, J. L. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2006.00117.x · Cited by 575
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Al-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Self-citationRole of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm
Soto, S. M. (2013) · Virulence · doi:10.4161/viru.23724 · Cited by 513
Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces
Kuhn, D. M., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.878-888.2002 · Cited by 485
Ramage, G. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf049 · Cited by 468
Antimicrobial Tolerance in Biofilms
Stewart, P. S. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0010-2014 · Cited by 450
Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance
Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., & Andes, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-06 · Cited by 407
“25 g/ml for fluconazole and amphotericin B, respectively [2, 6, 7, 9, 11, 15, 25, 30, 31, 47].”
BackgroundBiofilms of non-Candida albicans Candida species: quantification, structure and matrix composition
Silva, S., Henriques, M., Martins, A., Oliveira, R., Williams, D., & Azeredo, J. (2009) · Medical Mycology · doi:10.3109/13693780802549594 · Cited by 390
Baillie, G. S. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.3.397 · Cited by 389
Mixed species biofilms of Candida albicans and Staphylococcus epidermidis
ADAM, B., BAILLIE, G. S., & DOUGLAS, L. J. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-4-344 · Cited by 374
Self-citationRole of Biofilms in Antimicrobial Resistance
Donlan, R. M. (2000) · ASAIO Journal · doi:10.1097/00002480-200011000-00037 · Cited by 351
Biofilm lifestyle of Candida: a mini review
Seneviratne, C., Jin, L., & Samaranayake, L. (2008) · Oral Diseases · doi:10.1111/j.1601-0825.2007.01424.x · Cited by 317
Role of dimorphism in the development of Candida albicans biofilms
BAILLIE, G. S., & DOUGLAS, L. J. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-7-671 · Cited by 304
Self-citationCandida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
An Update on Candida tropicalis Based on Basic and Clinical Approaches
Zuza-Alves, D. L., Silva-Rocha, W. P., & Chaves, G. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01927 · Cited by 295
In Vitro Activity of Caspofungin against Candida albicans Biofilms
Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F., Wickes, B. L., Graybill, J. R., & López-Ribot, J. L. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3591-3596.2002 · Cited by 288
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Penetration of Candida Biofilms by Antifungal Agents
Al-Fattani, M. A., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3291-3297.2004 · Cited by 235
Self-citationEffect of Growth Rate on Resistance of Candida albicans Biofilms to Antifungal Agents
Baillie, G. S., & Douglas, L. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1900 · Cited by 234
“Overall, the results of this study have confirmed earlier findings (20) that biofilms of C.”
BackgroundResultInfluentialSelf-citationReview on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
Chaabane, F., Graf, A., Jequier, L., & Coste, A. T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02788 · Cited by 223
Alem, M. A. S., & Douglas, L. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.41-47.2004 · Cited by 205
“Drug resistance has been demonstrated for Candida biofilms growing on surfaces such as cellulose (3, 5), polystyrene (27, 28), and denture acrylic (6), as well as polyvinyl chloride (16).”
BackgroundVediyappan, G., Rossignol, T., & d'Enfert, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-09 · Cited by 183
“Moreover, the extent of the transcriptional response of biofilms to antifungals appeared well correlated to the efficacy of these antifungals toward biofilms, with caspofungin eliciting higher transcriptome alterations than amphotericin B and amphotericin B eliciting higher transcriptome alterations than fluconazole (…”
BackgroundRabbit Model of Candida albicans Biofilm Infection: Liposomal Amphotericin B Antifungal Lock Therapy
Schinabeck, M. K., Long, L. A., Hossain, M. A., Chandra, J., Mukherjee, P. K., Mohamed, S., & Ghannoum, M. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1727-1732.2004 · Cited by 180
“Data from several laboratories have demonstrated the neartotal resistance of in vitro Candida albicans biofilms to common antifungal agents (6, 7, 13, 15).”
BackgroundRole for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms
Perumal, P., Mekala, S., & Chaffin, W. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01237-06 · Cited by 165
Antifungal susceptibility of Candida albicans in biofilms
Tobudic, S., Kratzer, C., Lassnigg, A., & Presterl, E. (2012) · Mycoses · doi:10.1111/j.1439-0507.2011.02076.x · Cited by 165
Development and Validation of an In Vivo Candida albicans Biofilm Denture Model
Nett, J. E., Marchillo, K., Spiegel, C. A., & Andes, D. R. (2010) · Infection and Immunity · doi:10.1128/iai.00480-10 · Cited by 161
“Biofilm infections in general, 371 including those associated with dentures, are notoriously difficult to eradicate due to 372 associated resistance to both host defenses and anti-infective therapy (13, 26, 56).”
BackgroundNett, J. E., Cain, M. T., Crawford, K., & Andes, D. R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02273-10 · Cited by 153
“Other techniques used to assay the biofilm cell burden include [(3)H]leucine incorporation, fluorescein diacetate, crystal violet staining, viable counts, dry weight measurements, and imaging using confocal or electron microscopy (5, 8, 10, 35, 36).”
MethodCandida auris Infection and Biofilm Formation: Going Beyond the Surface
Horton, M. V., & Nett, J. E. (2020) · Current Clinical Microbiology Reports · doi:10.1007/s40588-020-00143-7 · Cited by 132
Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
Bonhomme, J., & d’Enfert, C. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.007 · Cited by 120
Fungicidal activity of miconazole against Candida spp. biofilms
Vandenbosch, D., Braeckmans, K., Nelis, H. J., & Coenye, T. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq019 · Cited by 113
Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole
Mateus, C., Crow, S. A., & Ahearn, D. G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3358-3366.2004 · Cited by 113
“Hawser and Douglas (12) reported that the MIC of amphotericin B was up to 200 times higher for biofilms of C.”
BackgroundThe Transcriptional Regulator Nrg1p Controls Candida albicans Biofilm Formation and Dispersion
Uppuluri, P., Pierce, C. G., Thomas, D. P., Bubeck, S. S., Saville, S. P., & Lopez-Ribot, J. L. (2010) · Eukaryotic Cell · doi:10.1128/ec.00111-10 · Cited by 110
“Of note, even in the absence of an extensive three-dimensional structure, attached cells already demonstrate increased levels of resistance to antifungal agents, particularly azole derivatives (9, 14), and this property may be further accentuated by the change in physiological status (nongrowing) associated with this…”
BackgroundCandida albicans biofilm formation is associated with increased anti‐oxidative capacities
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., & Samaranayake, L. P. (2008) · PROTEOMICS · doi:10.1002/pmic.200701097 · Cited by 104
Khot, P. D., Suci, P. A., Miller, R. L., Nelson, R. D., & Tyler, B. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-06 · Cited by 104
“albicans biofilms have been shown to be resistant to a variety of azoles, including fluconazole (36), voriconazole (46), miconazole (44), itraconazole (36), ketoconazole (36), the antiseptic chlorhexidine (15, 16), flucytosine (36), and the polyenes nystatin (15, 16) and amphotericin B (AmB) (15, 16, 36, 61, 62).”
BackgroundAlves, C. T., Ferreira, I. C., Barros, L., Silva, S., Azeredo, J., & Henriques, M. (2014) · Future Microbiology · doi:10.2217/fmb.13.147 · Cited by 102
Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450
Asai, K., Tsuchimori, N., Okonogi, K., Perfect, J. R., Gotoh, O., & Yoshida, Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1163 · Cited by 102
Absence of Amphotericin B-Tolerant Persister Cells in Biofilms of Some Candida Species
Al-Dhaheri, R. S., & Douglas, L. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01473-07 · Cited by 99
“Exposure to amphotericin B at a concentration of 5 gm l 1 effectively killed both exponential- and stationaryphase planktonic cells of strain GDH 2346, with no detectable survivors. The MIC for this strain is 1.3 gm l1 ( 9 ).”
BackgroundSelf-citationAntifungal Combinations against Candida albicans Biofilms In Vitro
Bachmann, S. P., Ramage, G., VandeWalle, K., Patterson, T. F., Wickes, B. L., & López-Ribot, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3657-3659.2003 · Cited by 89
Davis, L. E., Cook, G., & Costerton, J. W. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0804.010103 · Cited by 86
Apoptosis in Candida biofilms exposed to amphotericin B
Al-Dhaheri, R. S., & Douglas, L. J. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.015784-0 · Cited by 81
“…when treated with caspofungin and related echinocandins in vitro (Choi et al., 2007; Katragkou et al., 2008), they are resistant to most other clinically important antifungal agents, such as amphotericin B, fluconazole and voriconazole (Douglas, 2003; Hawser & Douglas, 1995; Ramage et al., 2005).”
BackgroundSelf-citationCandida albicans targets that potentially synergize with fluconazole
Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81
Pasqualotto, A. C., de Moraes, A. B., Zanini, R. R., & Severo, L. C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/516658 · Cited by 60
“Previous studies have demonstrated that most Candida species are able to produce a biofilm and that organisms in biofilms have an antimicrobial resistance profile than differs from that of freely suspended organisms.(23) In addition, it has been shown that retention of CVCs colonized with Candida organisms can increas…”
ResultRat Indwelling Urinary Catheter Model of Candida albicans Biofilm Infection
Nett, J. E., Brooks, E. G., Cabezas-Olcoz, J., Sanchez, H., Zarnowski, R., Marchillo, K., & Andes, D. R. (2014) · Infection and Immunity · doi:10.1128/iai.02284-14 · Cited by 58
O'Connor, L., Lahiff, S., Casey, F., Glennon, M., Cormican, M., & Maher, M. (2005) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2004.10.007 · Cited by 53
Candidaemia in Patients with an Inserted Medical Device
Cauda, R. (2009) · Drugs · doi:10.2165/11315520-000000000-00000 · Cited by 48
Efficacy of surface-generated nitric oxide against Candida albicans adhesion and biofilm formation
Privett, B. J., Nutz, S. T., & Schoenfisch, M. H. (2010) · Biofouling · doi:10.1080/08927014.2010.534552 · Cited by 45
“Fungal biofilms exhibit a greater resistance to antifungal agents (eg fluconazole and amphotericin B) than planktonic cells (Hawser and Douglas 1995 ; Chandra et al.”
BackgroundTruong, T., Zeng, G., Qingsong, L., Kwang, L. T., Tong, C., Chan, F. Y., Wang, Y., & Seneviratne, C. J. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.061523 · Cited by 45
Dorocka-Bobkowska, B., Konopka, K., & Düzgüneş, N. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(03)00174-2 · Cited by 32
Pentland, D. R., Davis, J., Mühlschlegel, F. A., & Gourlay, C. W. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00238-z · Cited by 28
Flow cytometry-based method to detect persisters in Candida albicans
Chang, W., Zhang, M., Li, Y., & Lou, H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00255-15 · Cited by 7
Metadata
- Authors
- Hawser, S. P., & Douglas, L. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1995-09
- Volume
- 39
- Issue
- 9
- Pages
- 2128-2131
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1992193993
- Cited by
- 406
- References
- 11
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.